€41.14
2.52% today
Xetra, Jun 26, 02:14 pm CET
ISIN
NL0000240000
Symbol
QIA
Sector

Qiagen Stock price

€40.13
+2.52 6.69% 1M
-4.11 9.30% 6M
-4.14 9.36% YTD
+0.31 0.79% 1Y
-7.16 15.15% 3Y
-0.67 1.65% 5Y
+15.68 64.12% 10Y
+29.48 276.87% 20Y
Xetra, Closing price Wed, Jun 25 2025
-0.24 0.59%
ISIN
NL0000240000
Symbol
QIA
Sector

Key metrics

Basic
Market capitalization
€8.8b
Enterprise Value
€9.0b
Net debt
€204.7m
Cash
€989.1m
Shares outstanding
216.1m
Valuation (TTM | estimate)
P/E
129.45 | 22.20
P/S
5.19 | 4.84
EV/Sales
5.31 | 4.95
EV/FCF
20.93
P/B
2.83
Dividends
DPS
€1.47
Yield 1Y | 5Y
3.66% | 1.23%
Growth 1Y | 5Y
17.41% | -
Payout 1Y | 3Y
379.52% | 38.30%
Increased
2 Years
Financials (TTM | estimate)
Revenue
€1.7b | €1.8b
EBITDA
€432.9m | €678.1m
EBIT
€424.6m
Net Income
€71.7m | €390.6m
Free Cash Flow
€430.9m
Growth (TTM | estimate)
Revenue
0.66% | 7.28%
EBITDA
10.64% | 56.67%
EBIT
11.16%
Net Income
-75.51% | 444.75%
Free Cash Flow
69.32%
Margin (TTM | estimate)
Gross
63.82%
EBITDA
25.51% | 37.25%
EBIT
25.02%
Net
4.23% | 21.46%
Free Cash Flow
25.39%
Financial Health
Equity Ratio
62.70%
Return on Equity
2.34%
ROCE
9.62%
ROIC
-
Debt/Equity
0.39
More
EPS
€0.31
FCF per Share
€1.99
Short interest
-
Employees
5.23k
Rev per Employee
€320.00k
Show more

Create a Free Account to create an Qiagen alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Qiagen Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Qiagen forecast:

12x Buy
55%
10x Hold
45%

Analyst Opinions

22 Analysts have issued a Qiagen forecast:

Buy
55%
Hold
45%

Financial data from Qiagen

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,697 1,697
1% 1%
100%
- Direct Costs 614 614
2% 2%
36%
1,083 1,083
2% 2%
64%
- Selling and Administrative Expenses 484 484
3% 3%
29%
- Research and Development Expense 166 166
3% 3%
10%
433 433
11% 11%
26%
- Depreciation and Amortization 8.23 8.23
11% 11%
0%
EBIT (Operating Income) EBIT 425 425
11% 11%
25%
Net Profit 72 72
76% 76%
4%

In millions EUR.

Don't miss a Thing! We will send you all news about Qiagen directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Head office United States
CEO Thierry Bernard
Employees 5,232
Founded 1996
Website www.qiagen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today